Comparative Effectiveness of 1 Month of Ticagrelor Plus Aspirin Followed by Ticagrelor Monotherapy Versus a Current-day Intensive Dual Antiplatelet Therapy in All-comers Patients Undergoing Percutaneous Coronary Intervention With Bivalirudin and BioMatrix Family Drug-eluting Stent Use
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 28 Mar 2018
At a glance
- Drugs Ticagrelor (Primary) ; Aspirin; Clopidogrel
- Indications Coronary artery disease; Stroke; Thrombosis; Venous thromboembolism
- Focus Adverse reactions
- Acronyms GLOBAL-LEADERS
- 28 Mar 2018 This trial has been completed in Netherlands.
- 13 Mar 2018 This trial has been completed in Spain.
- 21 Feb 2018 This trial has been completed in Germany.